Showing results (81-90 of 220) with videos related to

Sort By:
Pageof 22
Gastrointestinal Endoscopy|April 25, 2007
Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?David T Rubin, Jami A Rothe, Jeremy T Hetzel, et al.
Expert Review of Gastroenterology & Hepatology|May 26, 2025
The position of anti-tumor necrosis factor agents for the treatment of adult patients with Crohn's diseaseStephen B Hanauer, Byong Duk Ye, Raymond K Cross, et al.
BMC Gastroenterology|March 24, 2009
Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding studyClaudia Pena Rossi, Stephen B Hanauer, Ratko Tomasevic, et al.
Inflammatory Bowel Diseases|June 17, 2021
Posttraumatic Stress in Patients With Inflammatory Bowel Disease: Prevalence and Relationships to Patient-Reported OutcomesTiffany H Taft, Sarah Quinton, Sharon Jedel, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 15, 2014
Placebo response rate in clinical trials of fistulizing Crohn's disease: systematic review and meta-analysisAlexander C Ford, Pavit Luthra, Stephen B Hanauer, et al.
Journal of Crohn'S & Colitis|April 9, 2020
Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical OutcomesBritt Christensen, Stephen B Hanauer, Peter R Gibson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 6, 2010
Reinduction with certolizumab pegol in patients with relapsed Crohn's disease: results from the PRECiSE 4 StudyWilliam J Sandborn, Stefan Schreiber, Stephen B Hanauer, et al.
The American Journal of Gastroenterology|March 17, 2011
Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysisAlexander C Ford, William J Sandborn, Khurram J Khan, et al.
Inflammatory Bowel Diseases|April 2, 2011
Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral centerRussell D Cohen, Jeffrey R Lewis, Hannah Turner, et al.
Pageof 22